Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Medical Devices News and Events

Medical Devices News and Events

                        CDRH Newsletters
          CDRH Statements


                        CDRHNew - News and Updates
          Workshops & Conferences (Medical Devices) Home
          Medical Devices
          Medical Devices News and Events
          FDA Elevates Office of Strategic Partnerships and Technology Innovation to Super Office in CDRHMedical Devices News and Events FDA Elevates Office of Strategic Partnerships and Technology Innovation to Super Office in CDRH
  
  	
    Share
    Post
    Linkedin

    Email
    Print**FOR IMMEDIATE RELEASE
January 24, 2024**

*The following is attributed to Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health (CDRH) and Suzanne Schwartz, M.D., M.B.A., director of the Office of Strategic Partnerships and Technology Innovation (OST), CDRH*

CDRH is pleased to announce that, effective immediately, the Office of Strategic Partnerships and Technology Innovation (OST) has been elevated to a Super Office within the Center. The Super Office designation allows the Center, specifically OST, to be well-positioned and capable of adapting to and addressing future public health needs and challenges while continuing to advance the voice of patients, innovation and safety, regulatory science, and service excellence with our customers.

OST was stood up in 2019 as part of the Center’s vision to create an agile infrastructure capable of adapting to future organizational, regulatory, and scientific needs. Externally, OST provides leadership and strategic direction on medical device cybersecurity, digital health, standards, and patient science while providing oversight and coordination for CDRH in matters relating to public health emergency preparedness and response activities such as medical device supply chain resilience and shortage mitigation. Internally, in addition to providing expertise and program support in the above areas, OST directs the Center’s data, technology, and IT transformation services to ensure effective design, development, and utilization of information systems, electronic data, and analytic capabilities to optimize regulatory business processes.

By elevating OST to a Super Office, several organizational shifts will occur, including the establishment of the following five offices within OST: Office of Supply Chain Resilience (OSCR), Digital Health Center of Excellence (DHCoE), Office of Technology and Data Services (OTDS), Office of Readiness and Response (ORR), and Office of Equity and Innovative Development (OEID).

Key Office Highlights

OSCR will lead our Medical Device Resilient Supply Chain and Shortages Program to enhance, foster, and sustain resiliency in global medical device supply chains, as well as rapidly identify potential device shortages and mitigate and prevent device shortages.
	The elevation of the DHCoE to an office will allow the program to best meet today’s emerging challenges, particularly as digital health technologies play an increasing and significant role in bringing health care to the local community and into the home. Launched in the Fall of 2020, the DHCoE aims to connect and build partnerships to accelerate digital health advancement, share knowledge to increase awareness and understanding, drive synergy, advance best practices, and innovate regulatory approaches to provide efficient and least burdensome oversight while meeting FDA standards for safe and effective products.
	OTDS will continue to shepherd CDRH through and beyond our Digital Transformation Initiative, which aims to significantly improve the user experience for both internal and external CDRH customers and enhance CDRH’s ability to accept, store, analyze, and distribute data, and digitalize CDRH’s programs and operations. These efforts will support ongoing IT and data management needs to continually evolve and sustain the critical IT and data infrastructure that enables CDRH to meet our public health mission.
	ORR will address the areas of Medical Device Cybersecurity, Readiness and Response, and Standards. The office will further our readiness posture to tackle emergencies and public health threats, as well as drive the development, recognition, and appropriate use of voluntary consensus standards for medical devices. The new division dedicated to medical device cybersecurity will continue to support CDRH’s efforts to advance the cybersecurity posture of the medical device ecosystem and advance our national preparedness, response, and coordination for cybersecurity incidents involving medical devices by enhancing collaborations, optimizing operational responsiveness, and leveraging CDRH regulatory science capabilities through an integrated approach.
	The new OEID will be focused on advancing health equity by fostering device innovation that expands access to diverse patient populations, including underserved populations, and ensuring all patients have access to medical devices informed by solid patient science and engagement.As part of its public health mission, OST will continue to partner collaboratively with various medical device stakeholders, including patient organizations, health care professional organizations, industry, and scientific and other organizations in the U.S. and abroad. OST’s new structure will increase organizational capabilities and advance our efforts to meet MDUFA V commitments, as well as our 2022-2025 Strategic Priorities.

CDRH remains committed to serving the American public and ensuring our organization is well-positioned to fully achieve our mission and vision and meet emerging public health needs.

Additional Resources:

Office of Strategic Partnerships and Technology Innovation
	OST Super Office Reorganization Frequently Asked Questions (FAQs)
	CDRH Management Directory

                                                                                  Content current as of:
      01/24/2024Medical Devices News and Events

          
                        CDRH Newsletters
          CDRH Statements


                        CDRHNew - News and Updates
          Workshops & Conferences (Medical Devices)
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop